Cita APA

Manzano, J. L., Martin Liberal, J., Fernández Morales, L. A., Benítez, G., Medina Martínez, J., Quindós, M., . . . Cerezuela Fuentes, P. (2023). Adjuvant dabrafenib and trametinib for patients with resected BRAF-mutated melanoma: DESCRIBE-AD real-world retrospective observational study.

Citación estilo Chicago

Manzano, José L., et al. Adjuvant Dabrafenib and Trametinib for Patients With Resected BRAF-mutated Melanoma: DESCRIBE-AD Real-world Retrospective Observational Study. 2023.

Cita MLA

Manzano, José L., et al. Adjuvant Dabrafenib and Trametinib for Patients With Resected BRAF-mutated Melanoma: DESCRIBE-AD Real-world Retrospective Observational Study. 2023.